398 related articles for article (PubMed ID: 24612249)
1. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.
Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L
Addiction; 2014 Aug; 109(8):1306-17. PubMed ID: 24612249
[TBL] [Abstract][Full Text] [Related]
2. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L
Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260
[TBL] [Abstract][Full Text] [Related]
3. Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study.
Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L
BMJ Open; 2014 Apr; 4(4):e004666. PubMed ID: 24694626
[TBL] [Abstract][Full Text] [Related]
4. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
[TBL] [Abstract][Full Text] [Related]
5. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration.
Larney S; Toson B; Burns L; Dolan K
Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442
[TBL] [Abstract][Full Text] [Related]
6. Commentary on Degenhardt et al. (2014): Access to opioid substitution therapy in prison is not enough-the crucial role of post-release retention in preventing drug-related harms.
Stoové M; Kinner S
Addiction; 2014 Aug; 109(8):1318-9. PubMed ID: 25041202
[No Abstract] [Full Text] [Related]
7. Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release.
Bird SM; Fischbacher CM; Graham L; Fraser A
Addiction; 2015 Oct; 110(10):1617-24. PubMed ID: 25940815
[TBL] [Abstract][Full Text] [Related]
8. Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007-2013.
Larney S; Lai W; Dolan K; Zador D
J Subst Abuse Treat; 2016 Nov; 70():58-63. PubMed ID: 27692189
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
Larney S; Zador D; Sindicich N; Dolan K
Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women.
Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L
Drug Alcohol Rev; 2014 Sep; 33(5):499-505. PubMed ID: 24840554
[TBL] [Abstract][Full Text] [Related]
11. Engagement with the criminal justice system among opioid-dependent people: a retrospective cohort study.
Degenhardt L; Gisev N; Trevena J; Larney S; Kimber J; Burns L; Shanahan M; Weatherburn D
Addiction; 2013 Dec; 108(12):2152-65. PubMed ID: 23941286
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
[TBL] [Abstract][Full Text] [Related]
13. Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia.
Chaillon A; Bharat C; Stone J; Jones N; Degenhardt L; Larney S; Farrell M; Vickerman P; Hickman M; Martin NK; Bórquez A
Addiction; 2022 May; 117(5):1338-1352. PubMed ID: 34729841
[TBL] [Abstract][Full Text] [Related]
14. Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy.
Jerkeman A; Håkansson A; Rylance R; Wagner P; Alanko Blomé M; Björkman P
Drug Alcohol Rev; 2017 May; 36(3):424-431. PubMed ID: 27241955
[TBL] [Abstract][Full Text] [Related]
15. Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians.
Gisev N; Gibson A; Larney S; Kimber J; Williams M; Clifford A; Doyle M; Burns L; Butler T; Weatherburn DJ; Degenhardt L
BMC Public Health; 2014 Sep; 14():920. PubMed ID: 25192713
[TBL] [Abstract][Full Text] [Related]
16. Causes of death in a cohort treated for opioid dependence between 1985 and 2005.
Degenhardt L; Larney S; Randall D; Burns L; Hall W
Addiction; 2014 Jan; 109(1):90-9. PubMed ID: 23961881
[TBL] [Abstract][Full Text] [Related]
17. Opiate substitution treatment to reduce in-prison drug injection: a natural experiment.
Kinner SA; Moore E; Spittal MJ; Indig D
Int J Drug Policy; 2013 Sep; 24(5):460-3. PubMed ID: 23465644
[TBL] [Abstract][Full Text] [Related]
18. Continuity of opioid substitution treatment between prison and community in Southeast Asia: A scoping review.
Loh DA; Plugge E; Van Hout MC
Int J Drug Policy; 2023 Feb; 112():103957. PubMed ID: 36693296
[TBL] [Abstract][Full Text] [Related]
19. Optimising opioid substitution therapy in the prison environment.
Alam F; Wright N; Roberts P; Dhadley S; Townley J; Webster R
Int J Prison Health; 2019 Dec; 15(4):293-307. PubMed ID: 31532339
[TBL] [Abstract][Full Text] [Related]
20. The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study.
Vajdic CM; Marashi Pour S; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L
Drug Alcohol Depend; 2015 Jul; 152():264-71. PubMed ID: 25936861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
